Loading…
Comprehensive Opioid Abuse Reduction Act of 2016
Legislative Progress
Introduced
April 25, 2016
Latest Action
May 16, 2016
Primary Sponsor
F. James Sensenbrenner, Jr.Republican(WI)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
60pct
21d open
vs 6,526 other HR bills in the 114th — cohort avg 56d
Comprehensive Opioid Abuse Reduction Act of 2016 (Sec. 2) This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to authorize the Department of Justice (DOJ) to award grants to state, local, and tribal governments to provide opioid abuse services, including: enhancing collaboration between criminal justice and substance abuse agencies; developing, implementing, or expanding programs to prevent, treat, or respond to opioid abuse; training first responders to administer opioid overdose reversal drugs; and investigating unlawful opioid distribution activities. (Sec. 3) DOJ's Office of Inspector General must conduct annual audits of selected grant recipients. The bill prohibits grants to nonprofit organizations that hold money in an offshore account to avoid tax liability. (Sec. 4) The bill also authorizes DOJ to award grants to state, local, and tribal governments to establish or expand programs for veterans, including: veterans treatment courts; peer-to-peer services; treatment, rehabilitation, legal, or transitional services to incarcerated veterans; or training for relevant personnel to identify and appropriately respond to incidents. (Sec. 5) To offset the cost, the bill amends the Justice Assistance Act of 1984 to eliminate existing authority for DOJ to award grants under the Emergency Federal Law Enforcement Assistance Program through FY2021. (Sec. 6) It expands specified grant purposes under the Family-Based Substance Abuse Treatment Program to include prison-based family treatment programs for pregnant women. (Sec. 7) The Government Accountability Office must study and report to Congress on how DOJ grant programs address the prevention of, treatment for, and recovery from substance use and substance use disorders among adolescents and young adults.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (23)
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Motion to reconsider laid on the table Agreed to without objection.
On passage Passed by the Yeas and Nays: 413 - 5 (Roll no. 187).
HousePassed/agreed to in House: On passage Passed by the Yeas and Nays: 413 - 5 (Roll no. 187).
HouseThe House adopted the amendment in the nature of a substitute as agreed to by the Committee of the Whole House on the state of the Union. (text of amendment in the nature of a substitute: CR H2303-2304)
The previous question was ordered pursuant to the rule. (consideration: CR H2316)
The House rose from the Committee of the Whole House on the state of the Union to report H.R. 5046.
The House resolved into Committee of the Whole House on the state of the Union for further consideration.
Considered as unfinished business. (consideration: CR H2315-2317)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2016 · third_quarter · Health Issues
Cures (HR 6) and Mental Health Reform Bill (HR 2646); Support for health IT interoperability, mental health integration and mental health parity. Interest in Medicaid. S 2943 - Urge conferees on NDAA S 2943 to drop Tricare telehealth provision: Preserve state license-Physician is site of telehealth care. HR 2577, HR 5243 HR 4973 - Public Health/Emergency Funding: Funding for Zika emergency response: Public Health. Comprehensive Addiction & Recovery Act (CARA PL 114-198, S 524 HR 953 HR 1725 HR 4981 HR 4599 HR 3680 HR 4586 HR 4969 HR 4641 HR 5046:Support state prescription drug monitoring, treatment, naloxone, take-backs, partial fil & evidence based prescribing & treatment. HR 5325 Continuing Appropriations and Military Construction, Veterans Affairs, Appropriation Act, 2017 and Zika Response and Preparedness Act: Zika public health response funding in FY 2016 & FY 2017. S. 3040; HR 5926 - HHS FY 17 Appropriations priorities: AHRQ, HRSA, Title VII, NHSC, Title X, CARA: AAFP federal spending priorities for primary care training research and access. No Bill No. - Graduate Medical Education - Explain and advocate for AAFP's policy proposals on GME. No Bill No.-Graduate Medical Education: Pursue advancement of a bill to fix problem caused by "rotators" who establish low caps and PRAs. No Bill No. - Physician Payment Reform: Advocate for introduction of a House companion bill to allow HSA population access to direct primary care (DPC). No Bill No. - Physician Payment Reform: draft letter of support for permanence in the Independence at Home Demonstration model. No Bill No.-Graduate Medical Education: Advocate for solution to VACAA Expansion slots - how to fill them with more family medicine residents. No Bill No. - Graduate Medical Education: Advocate for the introduction of a bill to help resolve problems specific to the rural GME. No Bill No. - Graduate Medical Education: Advocate for introduction of a Resolution to support the stability in the Teaching Health Center GME program. No Bill No. - FY2018 appropriations for HRSA Title VII 747: Primary Care Training and Enhancement Grants. No Bill No. - Encourage House members to join Primary Care Caucus: Increase membership of the Primary Care Caucus. No Bill No. - Advisory Committee on Training in Primary Care Medicine and Dentistry: Increase support for Title VII. No Bill No. - Injury and Violence Prevention Network bfg: Preventing injury and death are key to public health. No Bill No. - Transforming Primary Care for 21st Century THC, GME and NHSC. No Bill N0. - Teaching Health Center Graduate Medical Education permanence: Increasing primary care workforce; maintain the sustainability of the THCGME program. No Bill No. - National Advisory Council on the National Health Service Corps: Medical student debt relief, improved access to primary care. No Bill No. - Coalition for Health Funding - AAFP Health is Primary booth: Raising awareness of AAFP and value of primary care; increasing primary care workforce. No Bill No. Medication Assisted Treatment for Opioid Use Disorders rule comments: Reduce administrative burden and increase MAT patient limit. No Bill No. - Letter to VA on APRNs re Concern with APRN expansion. No Bill No. - Letter to VA nominating FPs: Advisory Comm. on Women Veterans. No Bill No. - Letter to HHS nominating FPs: Advisory Comm. on Minority Health. No Bill No. - Letter to CDC nominating FPs: Advisory Comm. to the Director. No Bill No. - Letter to SAMHSA on opioid use: Opioid use disorder reporting. No Bill No. - Letter to CDC nominating FPs: Infection advisory committee. No Bill No. - Letter to CMS on patient relationship categories and codes: How to implement patient relationship categories and codes as required by MACRA. No Bill No. - Letter to CMS on 2017 proposed Medicare physician fee schedule: Comments on the 2017 regulation. No Bill No. - Letter to CMS on ESRD payment models: Not replacing fragmented FFS with fragmented APMs. No Bill No. - Letter nominating FPs to MEDCAC: Medicare coverage. No Bill No. - Letter to HHS on opioid prescribing education: Required CME. No Bill No. - Letter to HHS on contraceptive services: Expanding the availability of contraceptives. No Bill No. - Letter to VA on protected patient info: Support for allowing HIV and sickle cell negative results to be transmitted. Non Bill No. - Nominating FPs to CDC Committee: Health disparities subcommittee. No Bill No. - GME: Support for Teaching Health Center reauthorization; Maintain the sustainability of the THCGME program. No Bill No. - Health IT/Interoperability/Cures: Support for Health IT and interoperability legislation. No Bill No. - Mental Health reform: Support mental health reform integration and mental health parity. No Bill No. - Chronic Disease Bill: Support for eliminating the chronic care managemnt codes copayment. No Bill No. - Drug Pricing: Expressed interest in drug pricing generally. No Bill No - FY 2016 appropriations AHRQ, HRSA Title VII, NHSC: AAFP Federal spending priorities to support workforce, research. No Bill No. - Graduate Medical Education - Explain and advocate for AAFP's policy proposals on GME. No Bill No. - Congressional Primary Care Caucus - Urge members to join the Caucus and support Primary Care to achieve the triple aim in health care. No Bill No. - National Defense Authorization Act: Remove national licensure provisions in NDAA legislation health provisions. No Bill No. - Health Insurance Marketplace Issues and Provider Involvement with Patient Enrollment: Network Adequacy, Patient Enrollment in Marketplaces. No Bill No. - Children's Health Insurance: CHIP/Medicaid. No Bill No. - Medicaid: Medicaid alternative proposals.
Client expense: $749,400 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
2016 · third_quarter · Alcohol and Drug Abuse
Comprehensive Addiction & Recovery Act (CARA PL 114-198, S 524 HR 953 HR 1725 HR 4981 HR 4599 HR 3680 HR 4586 HR 4969 HR 4641 HR 5046:Support state prescription drug monitoring, treatment, naloxone, take-backs, partial fil & evidence based prescribing & treatment. No Bill No. - Medication assisted Treatment for Opioid Use Disorders rule comments; reduce administrative burden and increase MAT patient limit.
Client expense: $749,400 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
2016 · fourth_quarter · Health Issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60). Monitor federal and legislative activity related to Medicare Reimbursement. Monitor federal issues and legislation associated with health care policy. Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10). Monitor the implementation of Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act, 2017, and Zika Response and Preparedness Act (P.L. 114-223). H.R. 34, 21st Century CURES Act. (P.L. 114-255) H.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. S. 480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. H.R. 4227, Medicare Advantage Bill of Rights. S. 2392, Medicare Advantage Bill of Rights. H.R. 5046, Comprehensive Opioid Abuse Reduction Act of 2016. S. 3173, EHR Regulatory Relief Act. S. 3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017. H.R. 5926, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017. H.R. 2028, Further Continuing and Security Assistance Appropriations Act.
Client expense: Not reported · Firm income: $30,000
2016 · fourth_quarter · Budget/Appropriations
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60). Monitor federal and legislative activity related to Medicare Reimbursement. Monitor federal issues and legislation associated with health care policy. Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10). Monitor the implementation of Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act, 2017, and Zika Response and Preparedness Act (P.L. 114-223). H.R. 34, 21st Century CURES Act. (P.L. 114-255) H.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. S. 480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. H.R. 4227, Medicare Advantage Bill of Rights. S. 2392, Medicare Advantage Bill of Rights. H.R. 5046, Comprehensive Opioid Abuse Reduction Act of 2016. S. 3173, EHR Regulatory Relief Act. S. 3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017. H.R. 5926, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017. H.R. 2028, Further Continuing and Security Assistance Appropriations Act.
Client expense: Not reported · Firm income: $30,000
2016 · fourth_quarter · Medical/Disease Research/Clinical Labs
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60). Monitor federal and legislative activity related to Medicare Reimbursement. Monitor federal issues and legislation associated with health care policy. Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10). Monitor the implementation of Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act, 2017, and Zika Response and Preparedness Act (P.L. 114-223). H.R. 34, 21st Century CURES Act. (P.L. 114-255) H.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. S. 480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. H.R. 4227, Medicare Advantage Bill of Rights. S. 2392, Medicare Advantage Bill of Rights. H.R. 5046, Comprehensive Opioid Abuse Reduction Act of 2016. S. 3173, EHR Regulatory Relief Act. S. 3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017. H.R. 5926, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017. H.R. 2028, Further Continuing and Security Assistance Appropriations Act.
Client expense: Not reported · Firm income: $30,000
Committee of the Whole House on the state of the Union rises leaving H.R. 5046 as unfinished business.
On motion that the committee rise Agreed to by voice vote.
Mr. Goodlatte moved that the committee rise.
DEBATE - Pursuant to the provisions of H. Res. 720, the Committee of the Whole proceeded with 10 minutes of debate on the Clark(MA) Part B amendment No. 11.
DEBATE - Pursuant to the provisions of H. Res. 720, the Committee of the Whole proceeded with 10 minutes of debate on the Israel Part B amendment No. 10.
POSTPONED PROCEEDINGS - At the conclusion of debate on the Lynch amendment No. 9, the Chair put the question on adoption of the amendment and by voice vote announced that the noes had prevailed. Mr. Lynch demanded a recorded vote and the Chair postponed further proceedings on adoption of the amendment until later in the legislative day.
DEBATE - Pursuant to the provisions of H. Res. 720, the Committee of the Whole proceeded with 10 minutes of debate on the Lynch Part B amendment No. 9.
DEBATE - Pursuant to the provisions of H. Res. 720, the Committee of the Whole proceeded with 10 minutes of debate on the Keating Part B amendment No. 8.
DEBATE - Pursuant to the provisions of H. Res. 720, the Committee of the Whole proceeded with 10 minutes of debate on the Rothfus Part B amendment No. 7.
DEBATE - Pursuant to the provisions of H. Res. 720, the Committee of the Whole proceeded with 10 minutes of debate on the Guinta Part B amendment No. 6.
DEBATE - Pursuant to the provisions of H. Res. 720, the Committee of the Whole proceeded with 10 minutes of debate on the Bishop (MI) Part B amendment No. 5.
DEBATE - Pursuant to the provisions of H. Res. 720, the Committee of the Whole proceeded with 10 minutes of debate on the DeSaulnier Part B amendment No. 4.
DEBATE - Pursuant to the provisions of H. Res. 720, the Committee of the Whole proceeded with 10 minutes of debate on the DelBene Part B amendment No. 3.
DEBATE - Pursuant to the provisions of H. Res. 720, the Committee of the Whole proceeded with 10 minutes of debate on the Danny Davis Part B amendment No. 2.
DEBATE - Pursuant to the provisions of H.Res. 720, the Committee of the Whole proceeded with 10 minutes of debate on the Donovan Part B amendment No. 1.
GENERAL DEBATE - The Committee of the Whole proceeded with one hour of general debate on H.R. 5046.
The Speaker designated the Honorable Virginia Foxx to act as Chairwoman of the Committee.
House resolved itself into the Committee of the Whole House on the state of the Union pursuant to H. Res. 720 and Rule XVIII.
Resolution provides for consideration of H.R. 4641 and H.R. 5046 and makes specified amendments in order on each measure.
Considered under the provisions of rule H. Res. 720. (consideration: CR H2296-2315)
Rule H. Res. 720 passed House.
Rules Committee Resolution H. Res. 720 Reported to House. Resolution provides for consideration of H.R. 4641 and H.R. 5046 and makes specified amendments in order on each measure.
Placed on the Union Calendar, Calendar No. 415.
Reported by the Committee on Judiciary. H. Rept. 114-539.
Congress.gov source codes: 5000, H12200
Ordered to be Reported by Voice Vote.
Committee Consideration and Mark-up Session Held.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Referred to the House Committee on the Judiciary.
Introduced in House
Congress.gov source codes: 1000, Intro-H
| Referred to |
| April 25, 2016 |
| April 25, 2016 |
| Democratic |
| MI |
| Lamar Smith | Republican | TX |
| Mike Bishop | Republican | MI |
| Sheila Jackson Lee | Democratic | TX |
| Steve Chabot | Republican | OH |
| Tim Ryan | Democratic | OH |
| Vern Buchanan | Republican | FL |
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Medicare/Medicaid
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60). Monitor federal and legislative activity related to Medicare Reimbursement. Monitor federal issues and legislation associated with health care policy. Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10). Monitor the implementation of Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act, 2017, and Zika Response and Preparedness Act (P.L. 114-223). H.R. 34, 21st Century CURES Act. (P.L. 114-255) H.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. S. 480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. H.R. 4227, Medicare Advantage Bill of Rights. S. 2392, Medicare Advantage Bill of Rights. H.R. 5046, Comprehensive Opioid Abuse Reduction Act of 2016. S. 3173, EHR Regulatory Relief Act. S. 3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017. H.R. 5926, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017. H.R. 2028, Further Continuing and Security Assistance Appropriations Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Bankruptcy
H.R. 1927- Class Action and Asbestos reform H.R. 2076- Banking/marijuana H.R. 5046- Banking/marijuana S. 524- Banking/marijuana
Client expense: $790,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Deposit Insurance Corporation (FDIC), Federal Emergency Management Agency (FEMA), Federal Highway Administration (FHA), Federal Housing Finance Agency (FHFA), Federal Reserve System, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Internal Revenue Service (IRS), Natl Geospatial Intelligence Agency, Natl Highway Traffic Safety Administration (NHTSA), Natl Transportation Safety Board (NTSB), Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2016 · fourth_quarter · Health Issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60). Monitor federal and legislative activity related to Medicare Reimbursement. Monitor federal issues and legislation associated with health care policy. Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10). Monitor the implementation of Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act, 2017, and Zika Response and Preparedness Act (P.L. 114-223). H.R. 34, 21st Century CURES Act. (P.L. 114-255) H.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. S. 480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. H.R. 4227, Medicare Advantage Bill of Rights. S. 2392, Medicare Advantage Bill of Rights. H.R. 5046, Comprehensive Opioid Abuse Reduction Act of 2016. S. 3173, EHR Regulatory Relief Act. S. 3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017. H.R. 5926, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017. H.R. 2028, Further Continuing and Security Assistance Appropriations Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Budget/Appropriations
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60). Monitor federal and legislative activity related to Medicare Reimbursement. Monitor federal issues and legislation associated with health care policy. Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10). Monitor the implementation of Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act, 2017, and Zika Response and Preparedness Act (P.L. 114-223). H.R. 34, 21st Century CURES Act. (P.L. 114-255) H.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. S. 480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. H.R. 4227, Medicare Advantage Bill of Rights. S. 2392, Medicare Advantage Bill of Rights. H.R. 5046, Comprehensive Opioid Abuse Reduction Act of 2016. S. 3173, EHR Regulatory Relief Act. S. 3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017. H.R. 5926, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017. H.R. 2028, Further Continuing and Security Assistance Appropriations Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Medicare/Medicaid
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60). Monitor federal and legislative activity related to Medicare Reimbursement. Monitor federal issues and legislation associated with health care policy. Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10). Monitor the implementation of Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act, 2017, and Zika Response and Preparedness Act (P.L. 114-223). H.R. 34, 21st Century CURES Act. (P.L. 114-255) H.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. S. 480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. H.R. 4227, Medicare Advantage Bill of Rights. S. 2392, Medicare Advantage Bill of Rights. H.R. 5046, Comprehensive Opioid Abuse Reduction Act of 2016. S. 3173, EHR Regulatory Relief Act. S. 3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017. H.R. 5926, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017. H.R. 2028, Further Continuing and Security Assistance Appropriations Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Medical/Disease Research/Clinical Labs
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60). Monitor federal and legislative activity related to Medicare Reimbursement. Monitor federal issues and legislation associated with health care policy. Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10). Monitor the implementation of Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act, 2017, and Zika Response and Preparedness Act (P.L. 114-223). H.R. 34, 21st Century CURES Act. (P.L. 114-255) H.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. S. 480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. H.R. 4227, Medicare Advantage Bill of Rights. S. 2392, Medicare Advantage Bill of Rights. H.R. 5046, Comprehensive Opioid Abuse Reduction Act of 2016. S. 3173, EHR Regulatory Relief Act. S. 3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017. H.R. 5926, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017. H.R. 2028, Further Continuing and Security Assistance Appropriations Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Pharmacy
H.R. 2872 Opioid Addiction Treatment Modernization Act. H.R. 1821/S. 707 Opioid Overdose Reduction Act of 2015. H.R. 2536/S. 1455 TREAT ACT. H.R. 953/S. 524 Comprehensive Addiction and Recovery Act of 2016. H.R. 5046 Comprehensive Opioid Abuse Reduction Act. H.R. 4981 Opioid Use Disorder Treatment Expansion & Modernization Act. Controlled Substances act issues. H.R. 6 21st Century Cures Act.
Client expense: $48,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Health Issues
H.R. 2872 Opioid Addiction Treatment Modernization Act. H.R. 1821/S. 707 Opioid Overdose Reduction Act of 2015. H.R. 2536/S. 1455 TREAT ACT. H.R. 953/S. 524 Comprehensive Addiction and Recovery Act of 2016. H.R. 5046 Comprehensive Opioid Abuse Reduction Act. H.R. 4981 Opioid Use Disorder Treatment Expansion & Modernization Act. Controlled Substances act issues. H.R. 6 21st Century Cures Act.
Client expense: $48,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Alcohol and Drug Abuse
H.R. 2872 Opioid Addiction Treatment Modernization Act. H.R. 1821/S. 707 Opioid Overdose Reduction Act of 2015. H.R. 2536/S. 1455 TREAT ACT. H.R. 953/S. 524 Comprehensive Addiction and Recovery Act of 2016. H.R. 5046 Comprehensive Opioid Abuse Reduction Act. H.R. 4981 Opioid Use Disorder Treatment Expansion & Modernization Act. Controlled Substances act issues. H.R. 6 21st Century Cures Act.
Client expense: $48,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Health Issues
Issues relating to mental health and general health and health care legislation and regulation, including P.L. 111-148 (Patient Protection and Affordable Care Act) and P.L. 111-152 (Reconciliation Act of 2010). The health insurance excise tax, including H.R. 2050 and H.R. 879, S. 2045, the Middle Class Health Benefits Repeal Act of 2015, and S. 2075, the American Worker Health Care Tax Relief Act of 2015. S. 1945, the Mental Health Reform Act of 2015, S. 524 the Comprehensive Addiction and Recovery Act of 2016, and S. 2680, the Mental Health Reform Act of 2016; H.R. 5046 the Comprehensive Opioid Abuse Reduction Act and H.R. 2646 the Helping Family in Mental Crisis Act of 2016. Issues relating to employer sponsored healthcare.
Client expense: $1,420,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2016 · fourth_quarter · Health Issues
Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. Issues relating to FDA approvals of new drugs and generic drugs. Issues related to the FDA. Issues related to Opioids. Issues relating to Medicare Part D rebates. House 21st Century Cures bill (Senate companion which includes NIH and FDA issues). H.R. 471/S. 483: Ensuring Patient Access and Effective Drug Enforcement Act of 2015. Issues relating to the labeling of generic drugs. Issues relating to CDC guidance for prescribing opioids. S. 2948 and H.R. 5748 - The Medicaid Generic Drug Price Fairness Act. Issues relating to products containing high doses of acetaminophen. Issues relating to the labeling of generic drugs. Issues relating to removal of FDA unapproved products from the market. H.R. 5046: Comprehensive Opioid Abuse Reduction Act of 2016. S.524 - To authorize the Attorney General and Secretary of Health and Human Services to award grants to address the national epidemics of prescription opioid abuse and heroin use, and to provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES
2016 · fourth_quarter · Pharmacy
Legislation and policies relating to: H.R. 471/S. 483 - Ensuring Patient Access and Effective Drug Enforcement Act H.R. 639 - Improving Regulatory Transparency for New Medical Therapies Act H.R. 953/S. 524 - Comprehensive Addiction and Recovery Act of 2015 H.R. 2536/S. 1455 - Recovery Enhancement for Addiction Treatment (TREAT) Act H.R. 4435 - Comprehensive Behavioral Health Reform and Recovery Act of 2016 H.R. 4843 - Infant Plan of Safe Care Improvement Act H.R. 4978 - NAS Healthy Babies Act H.R. 4981 - Opioid Use Disorder Treatment Expansion and Modernization Act H.R. 5046 - Comprehensive Opioid Abuse Reduction Act of 2016 H.R. 5052 - Opioid Program Evaluation Act S. 1392 - Safe Prescribing of Controlled Substances Act S. 2423 - A bill making appropriations to address the heroin and opioid drug abuse epidemic for the fiscal year ending September 30, 2016, and for other purposes S. 3075 - Addiction Prevention and Responsible Opioid Practices Act S. 3223 - Expanded Access to Treatment and Recovery Act
Client expense: Not reported · Firm income: $23,450
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
2016 · fourth_quarter · Health Issues
Opioid response and recovery S. 524, H.R. 5046, H.R. 5052, 21st Century Cures Act
Client expense: Not reported · Firm income: $9,000
Government targets: HOUSE OF REPRESENTATIVES, Office on Violence Against Women, SENATE
2016 · fourth_quarter · Health Issues
Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. Issues relating to FDA approvals of new drugs and generic drugs. Issues related to the FDA Issues related to Opioids Issues relating to Medicare Part D rebates. House 21st Century Cures bill (Senate companion which includes NIH and FDA issues) H.R.471, S. 483 -Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S. 524 the Comprehensive Addiction and Recovery Act and related legislation H.R. 4641 Issues relating to the labeling of generic drugs. Issues relating to CDC guidance for prescribing opioids S. 2948 and H.R. 5748 - The Medicaid Generic Drug Price Fairness Act Issues relating to products containing high doses of acetaminophen. Issues relating to the labeling of generic drugs. Issues relating to removal of FDA unapproved products from the market HR 5046/S 524 - Opioid abuse legislation H.R.4641 - To provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Alcohol and Drug Abuse
Addiction related issues: Public Law 110-343, Mental Health Parity and Addiction Equity Act Public Law 114-198, Comprehensive Addiction and Recovery Act of 2015 H.R.5046, Comprehensive Opioid Abuse Reduction Act of 2016 Public Law 114-255, 21st Century Cures Act Public Law 114-254, Further Continuing and Security Assistance Appropriations Act, FY2017
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Health Issues
Addiction related issues: Public Law 110-343, Mental Health Parity and Addiction Equity Act Public Law 114-198, Comprehensive Addiction and Recovery Act of 2015 H.R.5046, Comprehensive Opioid Abuse Reduction Act of 2016 Public Law 114-255, 21st Century Cures Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Alcohol and Drug Abuse
S.1455, Recovery Enhancement for Addiction Treatment (TREAT) Act, Access to medication assisted treatment H.R.4981, Opioid Use Disorder Treatment Expansion and Modernization Act, Access to medication assisted treatment H.R.3691, Improving Treatment for Pregnant and Postpartum Women Act of 2016, Treatment for pregnant and postpartum women H.R.3680, Co-Prescribing to Reduce Overdoses Act of 2016, Naloxone coprescribing H.R.1725/S.480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015, Prescription drug monitoring H.R.4063, Promoting Responsible Opioid Management and Incorporating Scientific Expertise Act or the Jason Simcakoski PROMISE Act", Prescribing guidelines H.R.953/S.524, Comprehensive Addiction and Recovery Act of 2015, generally H.R.5046, Comprehensive Opioid Abuse Reduction Act of 2016 Public Law 114-255, 21st Century Cures Act, generally Public Law 114-254, Further Continuing and Security Assistance Appropriations Act, FY2017, generally
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2016 · fourth_quarter · Health Issues
S.1455, Recovery Enhancement for Addiction Treatment (TREAT) Act, Access to medication assisted treatment H.R.4981, Opioid Use Disorder Treatment Expansion and Modernization Act, Access to medication assisted treatment H.R.3691, Improving Treatment for Pregnant and Postpartum Women Act of 2016, Treatment for pregnant and postpartum women H.R.3680, Co-Prescribing to Reduce Overdoses Act of 2016, Naloxone coprescribing H.R.1725/S.480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015, Prescription drug monitoring H.R.4063, Promoting Responsible Opioid Management and Incorporating Scientific Expertise Act or the Jason Simcakoski PROMISE Act", Prescribing guidelines H.R.953/S.524, Comprehensive Addiction and Recovery Act of 2015, generally H.R.5046, Comprehensive Opioid Abuse Reduction Act of 2016, generally Public Law 114-255, 21st Century Cures Act, generally
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2016 · fourth_quarter · Alcohol and Drug Abuse
Public Law 111-152, Health Care and Education Reconciliation Act of 2010, Implementation of addiction treatment issues Public Law 110-343, Emergency Economic Stabilization Act of 2008, Regulations implementation, Mental health and addiction parity Public Law 111-148, Patient Protection and Affordable Care Act, Implementation of addiction treatment issues Prescription Drug abuse issues S.1455/H.R.2536, TREAT Act, Addiction treatment and recovery issues; 100 patient limit for buprenorphine prescribers S.524/H.R.953, Comprehensive Addiction and Recovery Act of 2015, Opioid abuse and treatment issues S.1392, Safer Prescribing of Controlled Substances Act, Prescriber education issues H.R.2872, Opioid Addiction Treatment Modernization Act, Opioid abuse and treatment issues H.R.2646, Helping Families in Mental Health Crisis Act of 2015, Parity and workforce issues S.2680, Mental Health Reform Act of 2016, Parity issues H.R.5046, Comprehensive Opioid Abuse Reduction Act of 2016 Public Law 114-255, 21st Century Cures Act Addition to #17 below: Center for Substance Abuse Treatment (CSAT)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2016 · fourth_quarter · Health Issues
HR 5046 and S 524 Conference Committee on opioid overdose reversal drug policy.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Health Issues
Issues relating to prescription drug abuse; issues relating to incentives for tamper-resistant formulations; issues relating to FDA approvals of new drugs and generic drugs; issues related to the FDA; issues related to Opioids; issues relating to Medicare Part D rebates; H.R. 6, 21st Century Cures bill (Senate companion which includes NIH and FDA issues); H.R.471, S. 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015; S. 524 the Comprehensive Addiction and Recovery Act and related legislation, including H.R. 4641 and H.R. 5046; issues relating to the labeling of generic drugs; issues relating to CDC guidance for prescribing opioids; S. 2948 and H.R. 5748 - The Medicaid Generic Drug Price Fairness Act; issues relating to products containing high doses of acetaminophen; issues relating to the labeling of generic drugs; issues relating to FDA policy, including marketed new drugs without approved NDAs or ANDAs; issues relating to removal of FDA unapproved products from the market such as KCL and Adrenalin; H.R. 5046/S. 524 - Opioid abuse legislation.
Client expense: $410,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Health Issues
Issues relating to prescription drug abuse; issues relating to incentives for tamper-resistant formulations; issues relating to FDA approvals of new drugs and generic drugs; issues related to the FDA; issues related to Opioids; issues relating to Medicare Part D rebates; House 21st Century Cures bill (Senate companion which includes NIH and FDA issues); H.R.471, S. 483 -Ensuring Patient Access and Effective Drug Enforcement Act of 2015; S. 524 the Comprehensive Addiction and Recovery Act and related legislation H.R. 4641; issues relating to the labeling of generic drugs; issues relating to CDC guidance for prescribing opioids; S. 2948 and H.R. 5748 - The Medicaid Generic Drug Price Fairness Act; issues relating to products containing high doses of acetaminophen; issues relating to the labeling of generic drugs; issues relating to removal of FDA unapproved products from the market; and HR 5046/S 524 - Opioid abuse legislation.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Bankruptcy
H.R. 1927- Class Action and Asbestos reform H.R. 2076- Banking/marijuana H.R. 5046- Banking/marijuana S. 524- Banking/marijuana
Client expense: $790,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Deposit Insurance Corporation (FDIC), Federal Emergency Management Agency (FEMA), Federal Highway Administration (FHA), Federal Housing Finance Agency (FHFA), Federal Reserve System, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Internal Revenue Service (IRS), Natl Geospatial Intelligence Agency, Natl Highway Traffic Safety Administration (NHTSA), Natl Transportation Safety Board (NTSB), Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2016 · fourth_quarter · Pharmacy
Pseudoephedrine Potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient, common in popular cold and allergy medications (no bill number) and oppose prescription requirement (no bill number). Extended Producer Responsibility/Pharmaceutical Stewardship (Drug Take-Back) H.R. 4931 - Pharmaceutical Stewardship Act of 2016. Requires the Drug Enforcement Administration to establish and implement a national pharmaceutical stewardship program to collect and dispose of prescription medications; all sections. H.R. 5046 - Comprehensive Opioid Abuse Reduction Act of 2016 (COARA). Amends the Omnibus Crime Control and Safe Streets Act of 1968 to authorize the Attorney General to make grants to assist State and local governments in addressing the national epidemic of opioid abuse, and for other purposes (all sections). S. 524 - Comprehensive Addiction and Recovery Act of 2016 (CARA; became P.L. 114-198 on 7/22/2016). Authorizes the Attorney General and Secretary of Health and Human Services to award grants to address the national epidemics of prescription opioid abuse and heroin use, and to provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes (Section 201 - expands eligible uses of grant funds to include drug take-back efforts; Section 203 requires coordination among multiple government agencies to develop a prescription drug take-back program). Oral Contraceptives H.R. 5138 - Over-the-Counter Contraceptives Act of 2016. Grants priority review of applications to switch oral contraceptive drugs from prescription to nonprescription (over-the-counter) status; all sections. S. 1438 - Allowing Greater Access to Safe and Effective Contraception Act. Grants priority review of applications to switch oral contraceptive drugs from prescription to nonprescription (over-the-counter) status; all sections. H.R. 3163/S. 1532 - Affordability is Access Act. Clarifies that all oral contraceptive products be covered by insurance and provided to consumers without cost, regardless of prescription/nonprescription (over-the-counter) status; all sections. Over-the-counter (OTC) medicines; Manufacturing and importation of OTC drugs; Mandatory recall authority of the FDA; Rx-to-OTC Switch Supporting a process within FDA that ensures clarity and timely outcomes for the FDA, applicants and stakeholders, as well as utilizing existing technologies to further streamline the prescription-to-nonprescription switch application process without changing the existing clear distinction between prescription and nonprescription medicines.
Client expense: $370,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
2016 · fourth_quarter · Alcohol and Drug Abuse
H.R. 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S. 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.524 - Comprehensive Addiction and Recovery Act of 2016 H.R.953 - Comprehensive Addiction and Recovery Act of 2015 HR 3250 - DXM Abuse Prevention Act S. 2294 - DXM Abuse Prevention Act H.R. 5046 - Comprehensive Opioid Abuse Reduction Act of 2016 H.R.4931 - Pharmaceutical Stewardship Act of 2016 S. 3075 - Addiction Prevention and Responsible Opioid Practices Act
Client expense: $380,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Government Issues
S. 192, Older Americans Act Reauthorization Act - entire bill H.R. 731, the Justice and Mental Health Collaboration Act - entire bill S. 933, the Comprehensive Justice and Mental Health Act - entire bill H.R. 988, the Elder Justice ActReauthorization Act - entire bill S. 1169, the Juvenile Justice and Delinquency Prevention Reauthorization Act - entire bill H.R. 1343/S. 688, the Establishing Beneficiary Equity in the Hospital Readmission Program Act - entire bill S. 1513, the Second Chance Act Reauthorization Act - entire bill H.R. 1865/S. 1423, the Central Coast Heritage Protection Act - entire bill S. 1964, the Family Stability & Kinship Care Act - entire bill S. 1879, the Interior Improvement Act - entire bill S. 1893, the Mental Health Awareness and Improvement Act - entire bill S. 1945, the Mental Health Reform Act - entire bill H.R. 2197, the Youth PROMISE Act - entire bill S. 2533/H.R. 5247, the California Long-Term Provisions for Water Supply and Short-Term Provisions for Emergency Drought Relief Act - entire bill S. 2565, the Protecting Families Affected By Substance Abuse Act - entire bill S. 2577/ H.R. 4602, the Justice For All Act Reauthorization Act of 2016 - entire bill H.R. 2646, the Helping Families in Mental Crisis Act - entire bill H.R. 2952, the Improving Employment Outcomes of TANF Recipients Act, - entire bill H.R. 3025, the Wildfire Airspace Protection Act - entire bill H.R. 3153, the Saint Francis Dam Memorial and Castaic Wilderness Act - entire bill S. 3270, the Elder Abuse Prevention and Prosecution Act - entire bill H.R. 3700, the Housing Opportunity Through Modernization Act - entire bill H.R. 4201, the Restoring the Partnership for County Health Care Costs Act - entire bill H.R. 4441, the Aviation Innovation, Reform, and Reauthorization Act - Airport Improvement Program/ Contract Tower Program; drone interference with wild fire fighting H.R. 4676, the Preventing Crimes Against Veterans Act - entire bill H.R. 4472/S. 2574, Modernizing the Interstate Placement of Children in Foster Care Act - entire bill H.R. 4724, the Reducing Duplicative and Ineffective Federal Funding Act - entire bill H.R. 4725, the Common Sense Savings Act - entire bill H.R. 5244, the Saint Francis Dam Memorial Act - entire bill H.R. 5273, the Helping Hospitals Improve Patient Care Act - entire bill H.R. 5456/S. 3065, the Family First Prevention Services Act - entire bill H.R. 5046, the Comprehensive Opioid Abuse Reduction Act - entire bill H.R. 5244, the Saint Francis Dam Disaster National Memorial Act - entire bill H.R. 5467, the Rim of the Valley Corridor Preservation Act - entire bill H.R. 5963, the Supporting Youth Opportunity and Preventing Delinquency Act H.R. 5054/S. 5296, FY 2017 Agriculture Appropriations - Agricultural Pests, APHIS funding, WIC H.R. 5393/S. 2837, FY 2017 Commerce, Justice, State Appropriations - funding for local law enforcement activities, including youth delinquency prevention, local law enforcement technology needs, domestic abuse programs, drug treatment, SCAAP, and the Southwest Border Prosecution Initiative H.R. 5055/S. 2804/H.R. 2028, FY 2017 Energy and Water Appropriations -Funding for Army Corps of Engineers projects H.R. 5634/S. 3001, FY 2017 Homeland Security Appropriations - local homeland security and disaster preparedness activities, including public safety, public health, emergency management personnel, communications infrastructure, Assistance to Firefighters Grant program, and Emergency Management Performance Grants H.R. 5538/S. 3068, FY 2017 Interior Appropriations - funding for EPA Section 103 & 105 air grants; Payments in Lieu of Taxes S. 3040, FY 2017 Labor, Health and Human Services Appropriations - funding for CDC State & Local Capacity, Bioterrorism Hospital Program, MMRS, MCH, ADAP, TB Control, family planning, substance abuse block grants, preventative health, safety net grants, nutritional services for older Americans, LSTA, Funding for Community Services and Social Services Block Grants, oral health funding H.R. 5394/S. 2844, FY 2017 Transportation, HUD Appropriations bill - CDBG, HOME Investment Partnerships, Homeless assistance grants, HOPWA, Elderly Housing, Airport Improvement Program, Contract Tower Program Federally Qualified Health Centers Managed care under the Medicaid and CHIP programs Temporary Assistance to Needy Families (TANF) Reauthorization 340B Hospital Drug program
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2016 · fourth_quarter · Government Issues
H.R. 211, the Reducing Environmental Barriers to Unified Infrastructure and Land Development (REBUILD) Act - entire bill S. 414, the California Desert Conservation and Recreation Act - entire bill S. 517, the Secure Rural Schools and Payment in Lieu of Taxes Act - entire bill H.R. 731, the Justice and Mental Health Collaboration Act - entire bill S. 933, the Comprehensive Justice and Mental Health Act - entire bill H.R. 988, the Elder Justice Act Reauthorization Act - entire bill S. 1169, the Juvenile Justice and Delinquency Prevention Reauthorization Act - entire bill H.R. 1211/S. 1588, the Mental Health in Schools Act - entire bill H.R. 1343/S. 688, the Establishing Beneficiary Equity in the Hospital Readmission Program Act - entire bill S. 1439/H.R. 3160, the Foster Youth Independence Act - entire bill S. 1513, the Second Chance Act Reauthorization Act - entire bill H.R. 1854/S. 993, the Comprehensive Justice and Mental Health Act - entire bill S. 1879, the Interior Improvement Act - entire bill S. 1893, the Mental Health Awareness and Improvement Act - entire bill S. 1945, the Mental Health Reform Act - entire bill H.R. 2197, the Youth PROMISE Act - entire bill S. 2533/H.R. 5247, the California Long-Term Provisions for Water Supply and Short-Term Provisions for Emergency Drought Relief Act - entire bill S. 2565, the Protecting Families Affected By Substance Abuse Act - entire bill S. 2577/H.R. 4602, the Justice For All Act Reauthorization Act of 2016 - entire bill H.R. 2646, the Helping Families in Mental Crisis Act - entire bill H.R. 2663, the Public Land Renewable Energy Development Act - entire bill H.R. 2952, the Improving Employment Outcomes of TANF Recipients Act - entire bill H.R. 3025, the Wildfire Airspace Protection Act - entire bill S. 3270, the Elder Abuse Prevention and Prosecution Act - entire bill H.R. 3700, the Housing Opportunity Through Modernization Act - entire bill H.R. 4076, the Treat Act - entire bill H.R. 4201, the Restoring the Partnership for County Health Care Costs Act - entire bill H.R. 4441, the Aviation Innovation, Reform, and Reauthorization Act - Airport Improvement Program; drone interference with wild fire fighting H.R. 4472/S. 2574, the Modernizing the Interstate Placement of Children in Foster Care Act - entire bill H.R. 4724, the Reducing Duplicative and Ineffective Federal Funding Act - entire bill H.R. 4725, the Common Sense Savings Act - entire bill H.R. 5046, the Comprehensive Opioid Abuse Reduction Act of 2016 - entire bill H.R. 5273, the Helping Hospitals Improve Patient Care Act - entire bill H.R. 5963, the Supporting Youth Opportunity and Preventing Deilnquency Act - entire bill H.R. 5456/S. 3065, the Family First Prevention Services Act - entire bill H.R. 5054/S. 5296, FY 2017 Agriculture Appropriations - Agricultural Pests, APHIS funding, WIC H.R. 5393/S. 2837, FY 2017 Commerce, Justice, State Appropriations - funding for local law enforcement activities, including youth delinquency prevention, local law enforcement technology needs, domestic abuse programs, drug treatment, SCAAP, and the Southwest Border Prosecution Initiative. H.R. 5055/S. 2804/H.R. 2028, FY 2017 Energy and Water Appropriations - funding for the Salton Sea H.R. 5634/S. 3001, FY 2017 Homeland Security Appropriations - local homeland security and disaster preparedness activities, including public safety, public health, emergency management personnel, communications infrastructure, Assistance to Firefighters Grant program, and Emergency Management Performance Grants H.R. 5538/S. 3068, FY 2017 Interior Appropriations - Section 6, Cooperative Endangered Species Conservation Fund, Payments in Lieu of Taxes S. 3040, FY 2017 Labor, Health and Human Services Appropriations - funding for CDC State & Local Capacity, Bioterrorism Hospital Program, MMRS, DMAT, MCH, Ryan White Title I, TB Control, family planning, substance abuse block grants, preventative health, nutrition services for older Americans, Federally Designated Health Professional Shortage Areas (HPSA), LSTA, Funding for Community Services and Social Services Block Grants H.R. 5394/S. 2844, FY 2017 Transportation, HUD Appropriations bill - CDBG, Section 8, HOME Investment Partnerships, homeless assistance, HOPWA, Elderly Housing, Airport Improvement Program funding. Base Closure and Realignment Commission (BRAC) EB-5 Visa Program reform Endangered Species Act/Habitat Conservation Intercept of Federal Tax Refunds for Delinquent Fines Older Americans Act reauthorization Salton Sea Restoration Project Temporary Assistance to Needy Families (TANF) Reauthorization Trans-Pacific Partnership - support for continued progress on negotiation and ratification by Congress 340B Hospital Drug program
Client expense: Not reported · Firm income: $45,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Bankruptcy
H.R. 1927- Class Action and Asbestos reform H.R. 2076- Banking/marijuana H.R. 5046- Banking/marijuana S. 524- Banking/marijuana
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Deposit Insurance Corporation (FDIC), Federal Emergency Management Agency (FEMA), Federal Highway Administration (FHA), Federal Housing Finance Agency (FHFA), Federal Reserve System, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Internal Revenue Service (IRS), Natl Geospatial Intelligence Agency, Natl Highway Traffic Safety Administration (NHTSA), Natl Transportation Safety Board (NTSB), Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2016 · third_quarter · Alcohol and Drug Abuse
Comprehensive Addiction & Recovery Act (CARA PL 114-198, S 524 HR 953 HR 1725 HR 4981 HR 4599 HR 3680 HR 4586 HR 4969 HR 4641 HR 5046:Support state prescription drug monitoring, treatment, naloxone, take-backs, partial fil & evidence based prescribing & treatment. No Bill No. - Medication assisted Treatment for Opioid Use Disorders rule comments; reduce administrative burden and increase MAT patient limit.
Client expense: $749,400 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
2016 · third_quarter · Health Issues
Cures (HR 6) and Mental Health Reform Bill (HR 2646); Support for health IT interoperability, mental health integration and mental health parity. Interest in Medicaid. S 2943 - Urge conferees on NDAA S 2943 to drop Tricare telehealth provision: Preserve state license-Physician is site of telehealth care. HR 2577, HR 5243 HR 4973 - Public Health/Emergency Funding: Funding for Zika emergency response: Public Health. Comprehensive Addiction & Recovery Act (CARA PL 114-198, S 524 HR 953 HR 1725 HR 4981 HR 4599 HR 3680 HR 4586 HR 4969 HR 4641 HR 5046:Support state prescription drug monitoring, treatment, naloxone, take-backs, partial fil & evidence based prescribing & treatment. HR 5325 Continuing Appropriations and Military Construction, Veterans Affairs, Appropriation Act, 2017 and Zika Response and Preparedness Act: Zika public health response funding in FY 2016 & FY 2017. S. 3040; HR 5926 - HHS FY 17 Appropriations priorities: AHRQ, HRSA, Title VII, NHSC, Title X, CARA: AAFP federal spending priorities for primary care training research and access. No Bill No. - Graduate Medical Education - Explain and advocate for AAFP's policy proposals on GME. No Bill No.-Graduate Medical Education: Pursue advancement of a bill to fix problem caused by "rotators" who establish low caps and PRAs. No Bill No. - Physician Payment Reform: Advocate for introduction of a House companion bill to allow HSA population access to direct primary care (DPC). No Bill No. - Physician Payment Reform: draft letter of support for permanence in the Independence at Home Demonstration model. No Bill No.-Graduate Medical Education: Advocate for solution to VACAA Expansion slots - how to fill them with more family medicine residents. No Bill No. - Graduate Medical Education: Advocate for the introduction of a bill to help resolve problems specific to the rural GME. No Bill No. - Graduate Medical Education: Advocate for introduction of a Resolution to support the stability in the Teaching Health Center GME program. No Bill No. - FY2018 appropriations for HRSA Title VII 747: Primary Care Training and Enhancement Grants. No Bill No. - Encourage House members to join Primary Care Caucus: Increase membership of the Primary Care Caucus. No Bill No. - Advisory Committee on Training in Primary Care Medicine and Dentistry: Increase support for Title VII. No Bill No. - Injury and Violence Prevention Network bfg: Preventing injury and death are key to public health. No Bill No. - Transforming Primary Care for 21st Century THC, GME and NHSC. No Bill N0. - Teaching Health Center Graduate Medical Education permanence: Increasing primary care workforce; maintain the sustainability of the THCGME program. No Bill No. - National Advisory Council on the National Health Service Corps: Medical student debt relief, improved access to primary care. No Bill No. - Coalition for Health Funding - AAFP Health is Primary booth: Raising awareness of AAFP and value of primary care; increasing primary care workforce. No Bill No. Medication Assisted Treatment for Opioid Use Disorders rule comments: Reduce administrative burden and increase MAT patient limit. No Bill No. - Letter to VA on APRNs re Concern with APRN expansion. No Bill No. - Letter to VA nominating FPs: Advisory Comm. on Women Veterans. No Bill No. - Letter to HHS nominating FPs: Advisory Comm. on Minority Health. No Bill No. - Letter to CDC nominating FPs: Advisory Comm. to the Director. No Bill No. - Letter to SAMHSA on opioid use: Opioid use disorder reporting. No Bill No. - Letter to CDC nominating FPs: Infection advisory committee. No Bill No. - Letter to CMS on patient relationship categories and codes: How to implement patient relationship categories and codes as required by MACRA. No Bill No. - Letter to CMS on 2017 proposed Medicare physician fee schedule: Comments on the 2017 regulation. No Bill No. - Letter to CMS on ESRD payment models: Not replacing fragmented FFS with fragmented APMs. No Bill No. - Letter nominating FPs to MEDCAC: Medicare coverage. No Bill No. - Letter to HHS on opioid prescribing education: Required CME. No Bill No. - Letter to HHS on contraceptive services: Expanding the availability of contraceptives. No Bill No. - Letter to VA on protected patient info: Support for allowing HIV and sickle cell negative results to be transmitted. Non Bill No. - Nominating FPs to CDC Committee: Health disparities subcommittee. No Bill No. - GME: Support for Teaching Health Center reauthorization; Maintain the sustainability of the THCGME program. No Bill No. - Health IT/Interoperability/Cures: Support for Health IT and interoperability legislation. No Bill No. - Mental Health reform: Support mental health reform integration and mental health parity. No Bill No. - Chronic Disease Bill: Support for eliminating the chronic care managemnt codes copayment. No Bill No. - Drug Pricing: Expressed interest in drug pricing generally. No Bill No - FY 2016 appropriations AHRQ, HRSA Title VII, NHSC: AAFP Federal spending priorities to support workforce, research. No Bill No. - Graduate Medical Education - Explain and advocate for AAFP's policy proposals on GME. No Bill No. - Congressional Primary Care Caucus - Urge members to join the Caucus and support Primary Care to achieve the triple aim in health care. No Bill No. - National Defense Authorization Act: Remove national licensure provisions in NDAA legislation health provisions. No Bill No. - Health Insurance Marketplace Issues and Provider Involvement with Patient Enrollment: Network Adequacy, Patient Enrollment in Marketplaces. No Bill No. - Children's Health Insurance: CHIP/Medicaid. No Bill No. - Medicaid: Medicaid alternative proposals.
Client expense: $749,400 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
2016 · third_quarter · Government Issues
S. 192, Older Americans Act Reauthorization Act - entire bill H.R. 731, the Justice and Mental Health Collaboration Act - entire bill S. 933, the Comprehensive Justice and Mental Health Act - entire bill H.R. 988, the Elder Justice ActReauthorization Act - entire bill S. 1169, the Juvenile Justice and Delinquency Prevention Reauthorization Act - entire bill H.R. 1343/S. 688, the Establishing Beneficiary Equity in the Hospital Readmission Program Act - entire bill S. 1513, the Second Chance Act Reauthorization Act - entire bill H.R. 1865/S. 1423, the Central Coast Heritage Protection Act - entire bill S. 1964, the Family Stability & Kinship Care Act - entire bill S. 1879, the Interior Improvement Act - entire bill S. 1893, the Mental Health Awareness and Improvement Act - entire bill S. 1945, the Mental Health Reform Act - entire bill H.R. 2197, the Youth PROMISE Act - entire bill S. 2533/H.R. 5247, the California Long-Term Provisions for Water Supply and Short-Term Provisions for Emergency Drought Relief Act - entire bill S. 2565, the Protecting Families Affected By Substance Abuse Act - entire bill S. 2577/ H.R. 4602, the Justice For All Act Reauthorization Act of 2016 - entire bill H.R. 2646, the Helping Families in Mental Crisis Act - entire bill H.R. 2952, the Improving Employment Outcomes of TANF Recipients Act, - entire bill H.R. 3025, the Wildfire Airspace Protection Act - entire bill H.R. 3153, the Saint Francis Dam Memorial and Castaic Wilderness Act - entire bill S. 3270, the Elder Abuse Prevention and Prosecution Act - entire bill H.R. 3700, the Housing Opportunity Through Modernization Act - entire bill H.R. 4201, the Restoring the Partnership for County Health Care Costs Act - entire bill H.R. 4441, the Aviation Innovation, Reform, and Reauthorization Act - Airport Improvement Program/ Contract Tower Program; drone interference with wild fire fighting H.R. 4676, the Preventing Crimes Against Veterans Act - entire bill H.R. 4472/S. 2574, Modernizing the Interstate Placement of Children in Foster Care Act - entire bill H.R. 4724, the Reducing Duplicative and Ineffective Federal Funding Act - entire bill H.R. 4725, the Common Sense Savings Act - entire bill H.R. 5244, the Saint Francis Dam Memorial Act - entire bill H.R. 5273, the Helping Hospitals Improve Patient Care Act - entire bill H.R. 5456/S. 3065, the Family First Prevention Services Act - entire bill H.R. 5046, the Comprehensive Opioid Abuse Reduction Act - entire bill H.R. 5244, the Saint Francis Dam Disaster National Memorial Act - entire bill H.R. 5467, the Rim of the Valley Corridor Preservation Act - entire bill H.R. 5963, the Supporting Youth Opportunity and Preventing Delinquency Act H.R. 5054/S. 5296, FY 2017 Agriculture Appropriations - Agricultural Pests, APHIS funding, WIC H.R. 5393/S. 2837, FY 2017 Commerce, Justice, State Appropriations - funding for local law enforcement activities, including youth delinquency prevention, local law enforcement technology needs, domestic abuse programs, drug treatment, SCAAP, and the Southwest Border Prosecution Initiative H.R. 5055/S. 2804/H.R. 2028, FY 2017 Energy and Water Appropriations -Funding for Army Corps of Engineers projects H.R. 5634/S. 3001, FY 2017 Homeland Security Appropriations - local homeland security and disaster preparedness activities, including public safety, public health, emergency management personnel, communications infrastructure, Assistance to Firefighters Grant program, and Emergency Management Performance Grants H.R. 5538/S. 3068, FY 2017 Interior Appropriations - funding for EPA Section 103 & 105 air grants; Payments in Lieu of Taxes S. 3040, FY 2017 Labor, Health and Human Services Appropriations - funding for CDC State & Local Capacity, Bioterrorism Hospital Program, MMRS, MCH, ADAP, TB Control, family planning, substance abuse block grants, preventative health, safety net grants, nutritional services for older Americans, LSTA, Funding for Community Services and Social Services Block Grants, oral health funding H.R. 5394/S. 2844, FY 2017 Transportation, HUD Appropriations bill - CDBG, HOME Investment Partnerships, Homeless assistance grants, HOPWA, Elderly Housing, Airport Improvement Program, Contract Tower Program Federally Qualified Health Centers Managed care under the Medicaid and CHIP programs Temporary Assistance to Needy Families (TANF) Reauthorization 340B Hospital Drug program
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2016 · third_quarter · Government Issues
H.R. 211, the Reducing Environmental Barriers to Unified Infrastructure and Land Development (REBUILD) Act - entire bill S. 414, the California Desert Conservation and Recreation Act - entire bill S. 517, the Secure Rural Schools and Payment in Lieu of Taxes Act - entire bill H.R. 731, the Justice and Mental Health Collaboration Act - entire bill S. 933, the Comprehensive Justice and Mental Health Act - entire bill H.R. 988, the Elder Justice Act Reauthorization Act - entire bill S. 1169, the Juvenile Justice and Delinquency Prevention Reauthorization Act - entire bill H.R. 1211/S. 1588, the Mental Health in Schools Act - entire bill H.R. 1343/S. 688, the Establishing Beneficiary Equity in the Hospital Readmission Program Act - entire bill S. 1439/H.R. 3160, the Foster Youth Independence Act - entire bill S. 1513, the Second Chance Act Reauthorization Act - entire bill H.R. 1854/S. 993, the Comprehensive Justice and Mental Health Act - entire bill S. 1879, the Interior Improvement Act - entire bill S. 1893, the Mental Health Awareness and Improvement Act - entire bill S. 1945, the Mental Health Reform Act - entire bill H.R. 2197, the Youth PROMISE Act - entire bill S. 2533/H.R. 5247, the California Long-Term Provisions for Water Supply and Short-Term Provisions for Emergency Drought Relief Act - entire bill S. 2565, the Protecting Families Affected By Substance Abuse Act - entire bill S. 2577/H.R. 4602, the Justice For All Act Reauthorization Act of 2016 - entire bill H.R. 2646, the Helping Families in Mental Crisis Act - entire bill H.R. 2663, the Public Land Renewable Energy Development Act - entire bill H.R. 2952, the Improving Employment Outcomes of TANF Recipients Act - entire bill H.R. 3025, the Wildfire Airspace Protection Act - entire bill S. 3270, the Elder Abuse Prevention and Prosecution Act - entire bill H.R. 3700, the Housing Opportunity Through Modernization Act - entire bill H.R. 4076, the Treat Act - entire bill H.R. 4201, the Restoring the Partnership for County Health Care Costs Act - entire bill H.R. 4441, the Aviation Innovation, Reform, and Reauthorization Act - Airport Improvement Program; drone interference with wild fire fighting H.R. 4472/S. 2574, the Modernizing the Interstate Placement of Children in Foster Care Act - entire bill H.R. 4724, the Reducing Duplicative and Ineffective Federal Funding Act - entire bill H.R. 4725, the Common Sense Savings Act - entire bill H.R. 5046, the Comprehensive Opioid Abuse Reduction Act of 2016 - entire bill H.R. 5273, the Helping Hospitals Improve Patient Care Act - entire bill H.R. 5963, the Supporting Youth Opportunity and Preventing Deilnquency Act - entire bill H.R. 5456/S. 3065, the Family First Prevention Services Act - entire bill H.R. 5054/S. 5296, FY 2017 Agriculture Appropriations - Agricultural Pests, APHIS funding, WIC H.R. 5393/S. 2837, FY 2017 Commerce, Justice, State Appropriations - funding for local law enforcement activities, including youth delinquency prevention, local law enforcement technology needs, domestic abuse programs, drug treatment, SCAAP, and the Southwest Border Prosecution Initiative. H.R. 5055/S. 2804/H.R. 2028, FY 2017 Energy and Water Appropriations - funding for the Salton Sea H.R. 5634/S. 3001, FY 2017 Homeland Security Appropriations - local homeland security and disaster preparedness activities, including public safety, public health, emergency management personnel, communications infrastructure, Assistance to Firefighters Grant program, and Emergency Management Performance Grants H.R. 5538/S. 3068, FY 2017 Interior Appropriations - Section 6, Cooperative Endangered Species Conservation Fund, Payments in Lieu of Taxes S. 3040, FY 2017 Labor, Health and Human Services Appropriations - funding for CDC State & Local Capacity, Bioterrorism Hospital Program, MMRS, DMAT, MCH, Ryan White Title I, TB Control, family planning, substance abuse block grants, preventative health, nutrition services for older Americans, Federally Designated Health Professional Shortage Areas (HPSA), LSTA, Funding for Community Services and Social Services Block Grants H.R. 5394/S. 2844, FY 2017 Transportation, HUD Appropriations bill - CDBG, Section 8, HOME Investment Partnerships, homeless assistance, HOPWA, Elderly Housing, Airport Improvement Program funding. Base Closure and Realignment Commission (BRAC) EB-5 Visa Program reform Endangered Species Act/Habitat Conservation Intercept of Federal Tax Refunds for Delinquent Fines Older Americans Act reauthorization Salton Sea Restoration Project Temporary Assistance to Needy Families (TANF) Reauthorization Trans-Pacific Partnership - support for continued progress on negotiation and ratification by Congress 340B Hospital Drug program
Client expense: Not reported · Firm income: $45,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Health Issues
S. 122: Safe and Affordable Drugs from Canada Act of 2015 - Provisions related to importation S. 185: Promise for Antibiotics and Therapeutics for Health (PATH) Act - Provisions related to antibiotic drug approval for a limited population S. 289: American Cures Act - Provisions related to National Institutes of Health (NIH) funding S. 320: Medical Innovation Act of 2015 - Provisions related to NIH funding and covered manufacturer supplemental fees S. 524: Comprehensive Addiction and Recovery Act of 2016 - Provisions related to opioids S. 1077: Advancing Breakthrough Devices for Patients Act of 2016 - Issues related to the biopharmaceutical industry S. 1597: Patient-Focused Impact Assessment Act of 2016 - Provisions related to patient-focused drug development S. 1790: Safe and Affordable Prescription Drugs Act of 2015 - Provisions related to importation S. 1767: Combination Product Regulatory Fairness Act of 2016 - Provisions related to improvements in the regulation of combination drug-device products S. 1878: Advancing Hope Act of 2016 - Provisions related to pediatric cancer and other pediatric diseases S.2055: Medical Countermeasure Innovation Act of 2015 S. 2512: Adding Zika Virus to the FDA Priority Review Voucher Program Act - Provisions related to priority review vouchers S. 2615: Increasing Competition in Pharmaceuticals Act - Provisions related to FDA review of generic drugs and study on risk evaluation and mitigation strategies (REMS) program S. 2680: Mental Health Reform Act of 2016 - Provisions related to mental health issues S. 2689: REGROW Act - Provisions related to creating a new regulatory pathway to speed the approval of certain stem cell treatments S. 2700: FDA and NIH Workforce Modernization Act - Provisions related to FDA and NIH S. 2912: Trickett Wendler Right to Try Act of 2016 - A bill to authorize the use of unapproved medical products by patients diagnosed with a terminal illness in accordance with State law, and for other purposes - Provisions related to use of unapproved medical products by patients with a terminal illness S. 3056: CREATES Act of 2016 - Provisions related to access to samples of prescription drugs S. 3239: RACE for Children Act - Provisions related to pediatric studies S. 3335: Fair Accountability and Innovative Research (FAIR) Drug Pricing Act - Provisions relating to transparency H.R. 6: 21st Century Cures Act - Provisions related to biopharmaceutical discovery, development, delivery and transparency H.R. 1537: Advancing Hope Act of 2015 - Provisions related to the pediatric rare disease voucher program H.R. 1538: Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2015 - Provisions related to regulation of marijuana and impact on medical research H.R. 2479: To amend the Federal Food, Drug, and Cosmetic Act to provide for the issuance of up-to-date regulations and guidance applying to the dissemination by means of the Internet of information about medical products - Provisions related to dissemination of information about medical products H.R. 2805: Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 - Provisions related to the treatment of heroin and prescription opioid abuse H.R. 2841: Fair Access for Safe and Timely Generics Act of 2015 or FAST Generics Act of 2015 - Provisions related to requiring innovator pharmaceutical manufacturers to provide samples of risk evaluation and mitigation strategy (REMS) covered products to generic manufacturers for bioequivalence testing H.R. 3012: Right to Try Act of 2015 - Provisions related to use of unapproved medical products by patients with a terminal illness H.R. 3250: DXM Abuse Prevention Act of 2015 H.R. 3299: The Strengthening Public Health Emergency Response Act of 2015 H.R. 3381: Childhood Cancer STAR Act - Provisions related to expanded access and other issues H.R. 4762: REGROW Act - Provisions related to creating a new regulatory pathway to speed the approval of certain stem cell treatments H.R. 4784: Lower Drug Costs Through Competition Act - Provisions related to generic drugs and priority review vouchers; REMS study; and tropical disease product applications H.R. 5046: Comprehensive Opioid Abuse Reduction Act of 2016 - Provisions related to opioids H.R. 5122: A bill to prohibit further action on the proposed rule regarding testing of Medicare Part B prescription drug models H.R. 5858: The RACE for Children Act - Provisions related to pediatric studies H.R. 6043: Fair Accountability and Innovative Research (FAIR) Drug Pricing Act of 2016 - Provisions related to transparency H.R. 6174: Closing Loopholes for Orphan Drugs Act - Provisions relating to 340B discounts on orphan drugs Other: - Kids Innovative Drugs Act (draft) - Incentives for the development of pediatric oncology drugs - The Regenerative Medicine Regulatory Improvement Act (discussion draft) - Provisions related to creating a new regulatory pathway to speed the approval of certain stem cell treatments - Kids Count Act of 2015 (discussion draft) - Provisions for incentivizing pediatric rare disease drug development - Discussion of Reforms to the Pediatric Research Equity Act (PREA) and Best Pharmaceuticals for Children Act (BPCA) - Incentives for the development of pediatric drugs - Food and Drug Administration Safety and Innovation Act (FDASIA) policy issues - Food and Drug Administration Proposed rule: Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products (78 Fed. Reg. 67985) - Provisions related to product labeling changes and related procedures - Senate HELP Committee innovation agenda - Provisions related to biopharmaceutical discovery and development and FDA policy - Proposed HRSA 340B program mega-guidance - Provisions related to 340B program - Implementation issues related to the Patient Protection and Affordable Care Act (PPACA) (Public Law 111-148), including health insurance exchanges - 340B Drug Discount Program policy issues - General FDA advocacy including sharing of truthful and non-misleading information about medicines with healthcare professionals - Prescription Drug User Fee Act (PDUFA) reauthorization - Biosimilar User Fee Act (BsUFA) reauthorization - Biologics Price Competition and Innovation Act (BPCIA) implementation issues - Biopharmaceutical and medical innovation policy issues - Drug development ecosystem policy issues - Drug cost and pricing policy issues - Expedited drug approval policy issues - Compassionate use policy issues - Biosimilar approval and reimbursement policy issues - Transparency policy issues - NIH Funding policy issues - Precision Medicine Initiative - Biomarker policy issues - Policy issues related to prescription drug abuse and secure disposal - Drug compounding policy issues - Prescription drug importation policy issues - Cancer Moonshot - Prescription drug take back policy issues - Clinical trial policy issues - Pediatric cancer policy issues - Cancer drug vial size policy issues - House Republican Health Proposal (A Better Way) - OTC Monograph Reform - Expanded access policy issues - Patient assistance program policy issues
Client expense: $640,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), Vice President of the U.S.
2016 · third_quarter · Health Issues
Issues relating to mental health and general health and health care legislation and regulation, including P.L. 111-148 (Patient Protection and Affordable Care Act) and P.L. 111-152 (Reconciliation Act of 2010). Issues related to the health insurance excise tax, including H.R. 2050 and H.R. 879, S. 2045, the Middle Class Health Benefits Repeal Act of 2015, and S. 2075, the American Worker Health Care Tax Relief Act of 2015. Issues related to S. 1945, the Mental Health Reform Act of 2015, S. 524 the Comprehensive Addiction and Recovery Act of 2016, and S. 2680, the Mental Health Reform Act of 2016; H.R. 5046 the Comprehensive Opioid Abuse Reduction Act and H.R. 2646 the Helping Family in Mental Crisis Act of 2016. Issues relating to employer sponsored healthcare.
Client expense: $1,050,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
2016 · third_quarter · Alcohol and Drug Abuse
Comprehensive Addiction & Recovery Act (CARA PL 114-198, S 524 HR 953 HR 1725 HR 4981 HR 4599 HR 3680 HR 4586 HR 4969 HR 4641 HR 5046:Support state prescription drug monitoring, treatment, naloxone, take-backs, partial fil & evidence based prescribing & treatment. No Bill No. - Medication assisted Treatment for Opioid Use Disorders rule comments; reduce administrative burden and increase MAT patient limit.
Client expense: $1,464,582 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
2016 · third_quarter · Health Issues
Cures (HR 6) and Mental Health Reform Bill (HR 2646); Support for health IT interoperability, mental health integration and mental health parity. Interest in Medicaid. S 2943 - Urge conferees on NDAA S 2943 to drop Tricare telehealth provision: Preserve state license-Physician is site of telehealth care. HR 2577, HR 5243 HR 4973 - Public Health/Emergency Funding: Funding for Zika emergency response: Public Health. Comprehensive Addiction & Recovery Act (CARA PL 114-198, S 524 HR 953 HR 1725 HR 4981 HR 4599 HR 3680 HR 4586 HR 4969 HR 4641 HR 5046:Support state prescription drug monitoring, treatment, naloxone, take-backs, partial fil & evidence based prescribing & treatment. HR 5325 Continuing Appropriations and Military Construction, Veterans Affairs, Appropriation Act, 2017 and Zika Response and Preparedness Act: Zika public health response funding in FY 2016 & FY 2017. S. 3040; HR 5926 - HHS FY 17 Appropriations priorities: AHRQ, HRSA, Title VII, NHSC, Title X, CARA: AAFP federal spending priorities for primary care training research and access. No Bill No. - Graduate Medical Education - Explain and advocate for AAFP's policy proposals on GME. No Bill No.-Graduate Medical Education: Pursue advancement of a bill to fix problem caused by "rotators" who establish low caps and PRAs. No Bill No. - Physician Payment Reform: Advocate for introduction of a House companion bill to allow HSA population access to direct primary care (DPC). No Bill No. - Physician Payment Reform: draft letter of support for permanence in the Independence at Home Demonstration model. No Bill No.-Graduate Medical Education: Advocate for solution to VACAA Expansion slots - how to fill them with more family medicine residents. No Bill No. - Graduate Medical Education: Advocate for the introduction of a bill to help resolve problems specific to the rural GME. No Bill No. - Graduate Medical Education: Advocate for introduction of a Resolution to support the stability in the Teaching Health Center GME program. No Bill No. - FY2018 appropriations for HRSA Title VII 747: Primary Care Training and Enhancement Grants. No Bill No. - Encourage House members to join Primary Care Caucus: Increase membership of the Primary Care Caucus. No Bill No. - Advisory Committee on Training in Primary Care Medicine and Dentistry: Increase support for Title VII. No Bill No. - Injury and Violence Prevention Network bfg: Preventing injury and death are key to public health. No Bill No. - Transforming Primary Care for 21st Century THC, GME and NHSC. No Bill N0. - Teaching Health Center Graduate Medical Education permanence: Increasing primary care workforce; maintain the sustainability of the THCGME program. No Bill No. - National Advisory Council on the National Health Service Corps: Medical student debt relief, improved access to primary care. No Bill No. - Coalition for Health Funding - AAFP Health is Primary booth: Raising awareness of AAFP and value of primary care; increasing primary care workforce. No Bill No. Medication Assisted Treatment for Opioid Use Disorders rule comments: Reduce administrative burden and increase MAT patient limit. No Bill No. - Letter to VA on APRNs re Concern with APRN expansion. No Bill No. - Letter to VA nominating FPs: Advisory Comm. on Women Veterans. No Bill No. - Letter to HHS nominating FPs: Advisory Comm. on Minority Health. No Bill No. - Letter to CDC nominating FPs: Advisory Comm. to the Director. No Bill No. - Letter to SAMHSA on opioid use: Opioid use disorder reporting. No Bill No. - Letter to CDC nominating FPs: Infection advisory committee. No Bill No. - Letter to CMS on patient relationship categories and codes: How to implement patient relationship categories and codes as required by MACRA. No Bill No. - Letter to CMS on 2017 proposed Medicare physician fee schedule: Comments on the 2017 regulation. No Bill No. - Letter to CMS on ESRD payment models: Not replacing fragmented FFS with fragmented APMs. No Bill No. - Letter nominating FPs to MEDCAC: Medicare coverage. No Bill No. - Letter to HHS on opioid prescribing education: Required CME. No Bill No. - Letter to HHS on contraceptive services: Expanding the availability of contraceptives. No Bill No. - Letter to VA on protected patient info: Support for allowing HIV and sickle cell negative results to be transmitted. Non Bill No. - Nominating FPs to CDC Committee: Health disparities subcommittee. No Bill No. - GME: Support for Teaching Health Center reauthorization; Maintain the sustainability of the THCGME program. No Bill No. - Health IT/Interoperability/Cures: Support for Health IT and interoperability legislation. No Bill No. - Mental Health reform: Support mental health reform integration and mental health parity. No Bill No. - Chronic Disease Bill: Support for eliminating the chronic care managemnt codes copayment. No Bill No. - Drug Pricing: Expressed interest in drug pricing generally. No Bill No - FY 2016 appropriations AHRQ, HRSA Title VII, NHSC: AAFP Federal spending priorities to support workforce, research. No Bill No. - Graduate Medical Education - Explain and advocate for AAFP's policy proposals on GME. No Bill No. - Congressional Primary Care Caucus - Urge members to join the Caucus and support Primary Care to achieve the triple aim in health care. No Bill No. - National Defense Authorization Act: Remove national licensure provisions in NDAA legislation health provisions. No Bill No. - Health Insurance Marketplace Issues and Provider Involvement with Patient Enrollment: Network Adequacy, Patient Enrollment in Marketplaces. No Bill No. - Children's Health Insurance: CHIP/Medicaid. No Bill No. - Medicaid: Medicaid alternative proposals.
Client expense: $1,464,582 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
2016 · third_quarter · Health Issues
Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. Issues relating to FDA approvals of new drugs and generic drugs. Issues related to the FDA Issues related to Opioids Issues relating to Medicare Part D rebates. House 21st Century Cures bill (Senate companion which includes NIH and FDA issues) H.R.471, S. 483 -Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S. 524 the Comprehensive Addiction and Recovery Act and related legislation H.R. 4641 Issues relating to the labeling of generic drugs. Issues relating to CDC guidance for prescribing opioids S. 2948 and H.R. 5748 - The Medicaid Generic Drug Price Fairness Act Issues relating to products containing high doses of acetaminophen. Issues relating to the labeling of generic drugs. Issues relating to removal of FDA unapproved products from the market HR 5046/S 524 - Opioid abuse legislation H.R.4641 - To provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Health Issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60). Monitor federal and legislative activity related to Medicare Reimbursement. Monitor federal issues and legislation associated with health care policy. Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10). Monitor the implementation of Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act, 2017, and Zika Response and Preparedness Act (P.L. 114-223). H.R. 6, House 21st Century Cures Act. H.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. S. 480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. H.R. 4227, Medicare Advantage Bill of Rights. S. 2392, Medicare Advantage Bill of Rights. H.R. 5046, Comprehensive Opioid Abuse Reduction Act of 2016. Senate 21st Century Cures Act counterpart package, including S. 2700, S.185, S.2713, S.2745, S.2742, S.1878, S.1077, S.1101, S.2055, S.1767, S.1597, S.2512, S.2030, S.1622, S.2014, S.800, S.849, S.2503, and S.2511. S. 3173, EHR Regulatory Relief Act. S. 3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017. Draft, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Budget/Appropriations
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60). Monitor federal and legislative activity related to Medicare Reimbursement. Monitor federal issues and legislation associated with health care policy. Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10). Monitor the implementation of Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act, 2017, and Zika Response and Preparedness Act (P.L. 114-223). H.R. 6, House 21st Century Cures Act. H.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. S. 480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. H.R. 4227, Medicare Advantage Bill of Rights. S. 2392, Medicare Advantage Bill of Rights. H.R. 5046, Comprehensive Opioid Abuse Reduction Act of 2016. Senate 21st Century Cures Act counterpart package, including S. 2700, S.185, S.2713, S.2745, S.2742, S.1878, S.1077, S.1101, S.2055, S.1767, S.1597, S.2512, S.2030, S.1622, S.2014, S.800, S.849, S.2503, and S.2511. S. 3173, EHR Regulatory Relief Act. S. 3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017. Draft, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Medical/Disease Research/Clinical Labs
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60). Monitor federal and legislative activity related to Medicare Reimbursement. Monitor federal issues and legislation associated with health care policy. Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10). Monitor the implementation of Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act, 2017, and Zika Response and Preparedness Act (P.L. 114-223). H.R. 6, House 21st Century Cures Act. H.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. S. 480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. H.R. 4227, Medicare Advantage Bill of Rights. S. 2392, Medicare Advantage Bill of Rights. H.R. 5046, Comprehensive Opioid Abuse Reduction Act of 2016. Senate 21st Century Cures Act counterpart package, including S. 2700, S.185, S.2713, S.2745, S.2742, S.1878, S.1077, S.1101, S.2055, S.1767, S.1597, S.2512, S.2030, S.1622, S.2014, S.800, S.849, S.2503, and S.2511. S. 3173, EHR Regulatory Relief Act. S. 3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017. Draft, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Medicare/Medicaid
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Monitor federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60). Monitor federal and legislative activity related to Medicare Reimbursement. Monitor federal issues and legislation associated with health care policy. Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10). Monitor the implementation of Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act, 2017, and Zika Response and Preparedness Act (P.L. 114-223). H.R. 6, House 21st Century Cures Act. H.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. S. 480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. H.R. 4227, Medicare Advantage Bill of Rights. S. 2392, Medicare Advantage Bill of Rights. H.R. 5046, Comprehensive Opioid Abuse Reduction Act of 2016. Senate 21st Century Cures Act counterpart package, including S. 2700, S.185, S.2713, S.2745, S.2742, S.1878, S.1077, S.1101, S.2055, S.1767, S.1597, S.2512, S.2030, S.1622, S.2014, S.800, S.849, S.2503, and S.2511. S. 3173, EHR Regulatory Relief Act. S. 3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017. Draft, House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY 2017.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Health Issues
S. 122: Safe and Affordable Drugs from Canada Act of 2015 - Provisions related to importation S. 185: Promise for Antibiotics and Therapeutics for Health (PATH) Act - Provisions related to antibiotic drug approval for a limited population S. 289: American Cures Act - Provisions related to National Institutes of Health (NIH) funding S. 320: Medical Innovation Act of 2015 - Provisions related to NIH funding and covered manufacturer supplemental fees S. 480: National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016 - Provisions related to the reauthorization of the national controlled substance monitoring program S. 524: Comprehensive Addiction and Recovery Act of 2016 - Provisions related to opioids S. 800: Enhancing the Stature and Visibility of Medical Rehabilitation Research at the NIH Act - Issues related to the biopharmaceutical industry S. 849: Advancing Research for Neurological Diseases Act of 2016 - Provisions related to research on neurological diseases S. 1077: Advancing Breakthrough Devices for Patients Act of 2016 - Issues related to the biopharmaceutical industry S. 1101: Medical Electronic Data Technology Enhancement for Consumers' Health Act - Provisions related to regulation of software S. 1455: Recovery Enhancement for Addiction Treatment Act - Provisions related to opioids S. 1597: Patient-Focused Impact Assessment Act of 2016 - Provisions related to patient-focused drug development S. 1622: FDA Device Accountability Act of 2016 - Issues related to the biopharmaceutical industry S. 1790: Safe and Affordable Prescription Drugs Act of 2015 - Provisions related to importation S. 1767: Combination Product Regulatory Fairness Act of 2016 - Provisions related to improvements in the regulation of combination drug-device products S. 1878: Advancing Hope Act of 2016 - Provisions related to pediatric cancer and other pediatric diseases S. 2014: Next Generation Researchers Act - Provisions related to NIH promoting new research. S. 2023: Prescription Drug Affordability Act of 2015 - Provisions related to importation S. 2030: Advancing Targeted Therapies for Rare Diseases Act of 2016 - Provisions related to rare disease treatment S. 2055: Medical Countermeasure Innovation Act of 2016 - Provisions related to priority review vouchers S. 2256: Co-Prescribing Saves Lives Act of 2015 - Provisions related to co-prescribing of opioids and reversal agents S. 2388: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2015 - Provisions related to reciprocity of drug approvals S. 2511: Improving Health Information Technology Act - Provisions related to health information technology (HIT) S. 2512: Adding Zika Virus to the FDA Priority Review Voucher Program Act - Provisions related to priority review vouchers S. 2615: Increasing Competition in Pharmaceuticals Act - Provisions related to FDA review of generic drugs and study on risk evaluation and mitigation strategies (REMS) program S. 2624: National Biomedical Research Act - Provisions related to mandatory funding for NIH and FDA S. 2680: Mental Health Reform Act of 2016 - Provisions related to mental health issues S. 2689: REGROW Act - Provisions related to creating a new regulatory pathway to speed the approval of certain stem cell treatments S. 2700: FDA and NIH Workforce Modernization Act - Provisions related to FDA and NIH S. 2713: Advancing Precision Medicine Act of 2016 - Provisions related to data sharing and security S. 2742: Promoting Biomedical Research and Public Health for Patients Act - Issues related to the biopharmaceutical industry S. 2912: A bill to authorize the use of unapproved medical products by patients diagnosed with a terminal illness in accordance with State law, and for other purposes - Provisions related to use of unapproved medical products by patients with a terminal illness S. 3056: CREATES Act of 2016 - Provisions related to access to samples of prescription drugs H.R. 6: 21st Century Cures Act - Provisions related to biopharmaceutical discovery, development, delivery and transparency H.R. 1537: Advancing Hope Act of 2015 - Provisions related to the pediatric rare disease voucher program H.R. 1538: Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2015 - Provisions related to regulation of marijuana and impact on medical research H.R. 2479: To amend the Federal Food, Drug, and Cosmetic Act to provide for the issuance of up-to-date regulations and guidance applying to the dissemination by means of the Internet of information about medical products - Provisions related to dissemination of information about medical products H.R. 2805: Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 - Provisions related to the treatment of heroin and prescription opioid abuse H.R. 2841: Fair Access for Safe and Timely Generics Act of 2015 - Provisions related to requiring innovator pharmaceutical manufacturers to provide samples of risk evaluation and mitigation strategy (REMS) covered products to generic manufacturers for bioequivalence testing H.R. 3012: Right to Try Act of 2015 - Provisions related to use of unapproved medical products by patients with a terminal illness H.R. 3250: DXM Abuse Prevention Act of 2015 - Issues related to prescription drug abuse H.R. 3381: Childhood Cancer STAR Act - Provisions related to expanded access and other issues H.R. 4762: REGROW Act - Provisions related to creating a new regulatory pathway to speed the approval of certain stem cell treatments H.R. 4784: Lower Drug Costs Through Competition Act - Provisions related to generic drugs and priority review vouchers; REMS study; and tropical disease product applications H.R. 5046: Comprehensive Opioid Abuse Reduction Act of 2016 - Provisions related to opioids H.R. 5127: Curb Opioid Abuse By Advancing Technology Act of 2016 - Provisions related to opioids Kids Innovative Drugs Act (draft) The Regenerative Medicine Regulatory Improvement Act (discussion draft) - Provisions related to creating a new regulatory pathway to speed the approval of certain stem cell treatments Kids Count Act of 2015 (discussion draft) - Provisions for incentivizing pediatric rare disease drug development ADF Incentive Act of 2015 (discussion draft) - Provisions providing manufacturers an incentive to develop abuse deterrent formulations (ADF) of controlled substances Drug Supply Chain Security Act policy issues Discussion of Reforms to the Pediatric Research Equity Act (PREA) and Best Pharmaceuticals for Children Act (BPCA) Food and Drug Administration Safety and Innovation Act (FDASIA) policy issues Food and Drug Administration Proposed rule: Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products (78 Fed. Reg. 67985) - Provisions related to product labeling changes and related procedures Senate HELP Committee innovation agenda - Provisions related to biopharmaceutical discovery and development and FDA policy Proposed HRSA 340B program mega-guidance - Provisions related to 340B program Implementation issues related to the Patient Protection and Affordable Care Act (PPACA) (Public Law 111-148), including health insurance exchanges 340B Drug Discount Program policy issues General FDA advocacy including sharing of truthful and non-misleading information about medicines with healthcare professionals Prescription Drug User Fee Act (PDUFA) negotiation and reauthorization Biologics Price Competition and Innovation Act (BPCIA) implementation issues Biopharmaceutical and medical innovation policy issues Drug development ecosystem policy issues Drug cost and pricing policy issues Expedited drug approval policy issues Compassionate use policy issues Biosimilar approval and reimbursement policy issues Transparency policy issues NIH Funding policy issues Precision Medicine Initiative Biomarker policy issues Policy issues related to prescription drug abuse and secure disposal Drug compounding policy issues Prescription drug importation policy issues Cancer Moonshot Prescription drug take back policy issues Clinical trial policy issues Pediatric cancer policy issues Cancer drug vial size policy issues House Republican Health Proposal (A Better Way)
Client expense: $4,550,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Security Council (NSC), Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
2016 · third_quarter · Pharmacy
Legislation and policies relating to: H.R. 471/S. 483 - Ensuring Patient Access and Effective Drug Enforcement Act H.R. 639 - Improving Regulatory Transparency for New Medical Therapies Act H.R. 953/S. 524 - Comprehensive Addiction and Recovery Act of 2015 H.R. 2536/S. 1455 - Recovery Enhancement for Addiction Treatment (TREAT) Act H.R. 4435 - Comprehensive Behavioral Health Reform and Recovery Act of 2016 H.R. 4843 - Infant Plan of Safe Care Improvement Act H.R. 4978 - NAS Healthy Babies Act H.R. 4981 - Opioid Use Disorder Treatment Expansion and Modernization Act H.R. 5046 - Comprehensive Opioid Abuse Reduction Act of 2016 H.R. 5052 - Opioid Program Evaluation Act S. 1392 - Safe Prescribing of Controlled Substances Act S. 2423 - A bill making appropriations to address the heroin and opioid drug abuse epidemic for the fiscal year ending September 30, 2016, and for other purposes S. 3075 - Addiction Prevention and Responsible Opioid Practices Act S. 3223 - Expanded Access to Treatment and Recovery Act
Client expense: Not reported · Firm income: $23,450
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
2016 · third_quarter · Health Issues
HR 5046 and S 524 Conference Committee on opioid overdose reversal drug policy.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Alcohol and Drug Abuse
H.R. 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S. 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.524 - Comprehensive Addiction and Recovery Act of 2016 H.R.953 - Comprehensive Addiction and Recovery Act of 2015 HR 3250 - DXM Abuse Prevention Act S. 2294 - DXM Abuse Prevention Act H.R. 5046 - Comprehensive Opioid Abuse Reduction Act of 2016 H.R.4931 - Pharmaceutical Stewardship Act of 2016 S. 3075 - Addiction Prevention and Responsible Opioid Practices Act
Client expense: $920,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE